Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SK-OV-3

An adenocarcinoma cell line established from the ascetic fluid of a 64 year old Caucasian female patient with ovarian carcinoma previously treated… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
PurposeAssessment of miR-424-3p mimic capability to sensitize SK-OV-3 and TOV-21G ovarian cancer cells to cisplatin by decreasing… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
Inflammation and inflammatory mediators are intimately linked with chemoresistance through complex pathways in the tumor… Expand
Highly Cited
2014
Highly Cited
2014
The therapeutic potential of mixed micelles, made of PEG-PE and vitamin E co-loaded with curcumin and paclitaxel, was… Expand
  • table 1
  • figure 3
  • figure 4
  • figure 6
2012
2012
Using gas chromatography, data analysis is performed on a dataset consisting of 486 retention indices, 27 standards (ramified… Expand
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2006
Highly Cited
2006
OBJECTIVE Interactions between estrogen receptor signaling and the PI3K/Akt pathway are present in estrogen-dependent cancer… Expand
2006
2006
OBJECTIVES The resistance of tumor cells to cisplatin remains a major cause of treatment failure in cancer patients. In this… Expand
2005
2005
11,11′-Dideoxy-verticillin, a compound of the novel epidithiodioxopiprazine structural class, is isolated from the traditional… Expand
2005
2005
Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) has been shown to induce apoptosis in numerous transformed cell… Expand
Highly Cited
1997
Highly Cited
1997
Amplification and overexpression of theHER-2/neu proto-oncogene frequently coincide with an aggressive clinical course of certain… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1993
Highly Cited
1993
Amplification or overexpression of c-erbB-2/neu protooncogene, or both, occur frequently in many different types of human cancers… Expand
  • figure 2
  • figure I
  • figure 3
  • figure 4
  • figure 5